Michelle M. O’Shaughnessy

Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

Timothy H.J. Goodship, H. Terence Cook, Fádi Fakhouri et al. · Kidney International · 2016 · 695 citations · Full text

Medicine, Nephrology, Pathology +17

Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Jürgen Floege, Sean Barbour, Daniel Cattran et al. · Kidney International · 2019 · 258 citations · Full text

Medicine, Internal Medicine, Nephrology +17

C3 Glomerulopathy

Nicholas Medjeral‐Thomas, Michelle M. O’Shaughnessy, John O’Regan et al. · Clinical Journal of the American Society of Nephrology · 2013 · 251 citations

Medicine, Nephrology, Pathology +16

Glomerular disease frequencies by race, sex and region: results from the International Kidney Biopsy Survey

Michelle M. O’Shaughnessy, Susan L. Hogan, Bawana D. Thompson et al. · Nephrology Dialysis Transplantation · 2017 · 235 citations · Full text

Medicine, Nephrology, Comparative Epidemiology +11

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 215 citations · Full text

Medicine, Internal Medicine, Nephrology +12